Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 2 |
2023 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Biomarker-Guided Anti-Egfr Rechallenge Therapy in Metastatic Colorectal Cancer.
Cancers (Basel). 2021 Apr 17;13(8):1941. doi: 10.3390/cancers13081941.
Cancers (Basel). 2021.
PMID: 33920531
Free PMC article.
Review.
Pretreatment Plasma Circulating Tumor DNA RAS/BRAF Mutational Status in Refractory Metastatic Colorectal Cancer Patients Who Are Candidates for Anti-EGFR Rechallenge Therapy: A Pooled Analysis of the CAVE and VELO Clinical Trials.
Ciardiello D, Napolitano S, Famiglietti V, Esposito L, De Falco V, Di Liello A, Avallone A, Maiello E, Pietrantonio F, Cremolini C, Zampino MG, Fazio N, Troiani T, Martinelli E, Ciardiello F, Martini G.
Ciardiello D, et al.
Cancers (Basel). 2023 Apr 1;15(7):2117. doi: 10.3390/cancers15072117.
Cancers (Basel). 2023.
PMID: 37046778
Free PMC article.
Item in Clipboard
Skin Toxicity as Predictor of Survival in Refractory Patients with RAS Wild-Type Metastatic Colorectal Cancer Treated with Cetuximab and Avelumab (CAVE) as Rechallenge Strategy.
Ciardiello D, Famiglietti V, Napolitano S, Esposito L, Normanno N, Avallone A, Latiano T, Maiello E, Pietrantonio F, Cremolini C, Santabarbara G, Pinto C, Troiani T, Martinelli E, Ciardiello F, Martini G.
Ciardiello D, et al.
Cancers (Basel). 2021 Nov 15;13(22):5715. doi: 10.3390/cancers13225715.
Cancers (Basel). 2021.
PMID: 34830870
Free PMC article.
Item in Clipboard
Cite
Cite